Lind Global Fund II LP 13D/13G Filings for Biocept, Inc. (BIOCQ)

Lind Global Fund II LP 13D and 13G filings for Biocept, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-06-02
4:26 pm
Purchase
2023-05-26 13G Biocept, Inc.
BIOCQ
Lind Global Fund II LP 147,294
9.900%
147,294increase
(New Position)
Filing